In a press release today, KPW Law firm announced that the Five Pennsylvania Essure cases made it past preemption!
Health & Medicine
I can finally write that the FDA has done something right! Albeit, with no fanfare, the FDA changed regulations to prevent another Martin Shkreli from jacking up drug prices unreasonably.
Everyone knows that it’s crucial for doctors and nurses to wash their hands in an effort to prevent the spread of infection in healthcare facilities. But what about the patients? A new study shows that patients leave hospitals carrying superbugs on their hands.
The Department of Health and Human Services issued the following Public Comment Instructions for FDA Essure Guidance re: Docket No. FDA-2016-D-0435]. I strongly urge all E-Sisters, Mad Men of Essure, families, supporters, doctors, caregivers, friends and anyone concerned with the crime against womens’ health known as Essure to follow these instructions and let the FDA know your opinion
An announcement from the Department of Veterans Affairs earlier this week showed that the organization is actually paying attention to some things. While it’s not patient care improvement or shortening wait times for veterans to get much needed health care, the VA took disciplinary action against appeals staffers for inappropriate conduct on the job.
Those of us who advocate for the removal of Bayer’s “permanent” birth control device, Essure, from the market, as well as the tens of thousands of innocent victims whose lives this product has destroyed have waited since September 2015 for the FDA to take action to protect innocent women. All the waiting was for naught, sadly. The FDA failed women and left deadly Essure on market.
According to the letter, plaintiffs’ counsel contacted a Mirena doctor violating court orders. Judge Seibel had previously issued a Case Management Order (CMO 21) that prohibited plaintiffs’ attorneys “from engaging in ex parte discussions with plaintiffs’ providers [doctors] concerning liability issues or theories.”
Rep. Rosa DeLauro spoke out against Essure during a meeting of the Appropriations Committee on February 25, 2016. The video – a short four-minutes – shows her impassioned speech, her tough questions to the FDA and the agency’s unsurprising lackluster responses. Though the numbers Rep. DeLauro opened with were lower than the actual numbers (but